Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 16.6
1.41 %
$ 766 M
Market Cap
-8.38
P/E
CASH FLOW STATEMENT
155 M
OPERATING CASH FLOW
77.5 M
INVESTING CASH FLOW
-183 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Pacira BioSciences, Inc.
| Net Income | 42 M |
| Depreciation & Amortization | 75.6 M |
| Capital Expenditures | -15.2 M |
| Stock-Based Compensation | 47.9 M |
| Change in Working Capital | -45.8 M |
| Others | -11.9 M |
| Free Cash Flow | 139 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||||||
| Net Income | 42.0 | 15.9 | 42.0 | 145.5 | (11.0) | (0.5) | (42.6) | (37.9) | 1.9 | (13.7) | (63.9) | (52.3) | (43.3) | (27.1) | (31.7) | (41.9) |
| Depreciation & Amortization | 75.6 | 91.5 | 28.5 | 19.9 | 19.6 | 13.2 | 13.8 | 12.9 | 11.5 | 10.0 | 5.7 | 5.6 | 4.3 | 4.3 | 4.4 | 3.8 |
| Deferred Income Tax | 15.6 | (7.9) | 10.9 | (126.6) | 5.3 | 0.9 | 5.9 | 0.4 | 58 K | 0.2 | 3.4 | 1.1 | 48.2 | 11 K | 1.7 | 0.4 |
| Stock Based Compensation | 47.9 | 48.1 | 42.2 | 39.9 | 33.6 | 31.7 | 31.6 | 31.2 | 33.4 | 24.8 | 11.5 | 4.8 | 2.5 | 23 K | 0.5 | 0.2 |
| Other Operating Activities | 19.4 | 14.2 | 20.7 | 22.7 | 31.8 | 14.4 | 11.7 | 4.6 | 4.6 | 4.6 | 4.4 | 0.6 | (45.1) | (0.7) | 0.2 | (5.2) |
| Change in Working Capital | (45.8) | (16.4) | (18.7) | (24.4) | (8.8) | (10.9) | (2.6) | 22.3 | (22.3) | (0.5) | (4.4) | (29.9) | 2.5 | (1.3) | 4.0 | 13.4 |
| Cash From Operations | 154.6 | 145.3 | 125.7 | 77.0 | 70.5 | 48.9 | 17.8 | 33.5 | 29.0 | 25.5 | (43.2) | (70.1) | (31.0) | (24.9) | (20.8) | (29.2) |
| INVESTING CASH FLOW | ||||||||||||||||
| Capital Expenditures | (15.2) | (30.1) | (45.9) | (37.8) | (10.2) | (14.5) | (19.3) | (24.7) | (41.3) | (21.9) | (12.8) | (18.3) | (6.2) | (6.8) | (5.5) | (5.8) |
| Other Items | 92.7 | (195.1) | 25.1 | (239.8) | (118.3) | 35.1 | (204.5) | (37.0) | 21.0 | (97.5) | (30.8) | (11.3) | (30.0) | 1 K | 0 | 2 K |
| Cash From Investing Activities | 77.5 | (225.2) | (20.8) | (277.6) | (128.5) | 20.6 | (223.8) | (61.8) | (20.2) | (119.3) | (43.6) | (29.5) | (36.1) | (6.8) | (5.5) | (5.8) |
| FINANCING CASH FLOW | ||||||||||||||||
| Common Stock Repurchased | (0.1) | 3.0 | 2.8 | (33.1) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 K | 0 | 0 |
| Total Debt Repaid | (180.8) | (427.7) | 363.8 | 192.6 | (0.3) | 0 | 226.8 | 4 K | (1.5) | 0 | 92.5 | 1.2 | 0 | 50.7 | 21.0 | 0 |
| Dividends Paid | 0 | 0 | (2.7) | (1.6) | (4.3) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (2.2) | 26.2 | 16.9 | 31.3 | 4.0 | 9.0 | (2.6) | 7.3 | 12.2 | 8.4 | (3.3) | (0.5) | 0.1 | 2 K | 3 K | 40.2 |
| Cash From Financing Activities | (183.0) | (401.5) | 380.7 | 222.3 | 3.7 | 9.0 | 224.2 | 7.3 | 10.7 | 118.9 | 89.2 | 63.6 | 87.2 | 50.7 | 21.0 | 40.2 |
| CHANGE IN CASH | ||||||||||||||||
| Net Change In Cash | 49.2 | (481.4) | 485.6 | 21.7 | (54.3) | 78.4 | 18.2 | (21.0) | 19.5 | 25.0 | 2.4 | (36.0) | 20.0 | 19.1 | (5.3) | 5.1 |
| FREE CASH FLOW | ||||||||||||||||
| Free Cash Flow | 139.5 | 115.2 | 79.9 | 39.2 | 60.4 | 34.4 | (1.5) | 8.7 | (12.3) | 3.6 | (56.0) | (88.4) | (37.2) | (31.6) | (26.3) | (35.0) |